Bravo shocked fans when they confirmed earlier this week that the series had been paused after two series, with the show's ...

Many of us were shocked by the recent election results and never saw the rightward swing coming. But when you weigh it in the context of fashion and beauty trends, the canaries in the proverbial ...

Before the class of 2024 make it to the Australian outback, the famous faces will have to ditch to glamour and make sure they ...

The action movie has a stellar ensemble cast led by Ajay Devgn. In an exclusive conversation with Pinkvilla, director Rohit ...

Today, Netflix dropped the reunion for its seventh season of Love Is Blind. Amid all the drama about relationships, cast member Hannah Jiles debuted a weight-loss transformation. Ahead of the reunion, ...

After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as "available" on the U.S. Food and Drug Administration's drug shortage list.

Hims & Hers Health Inc. said an analysis of more than 10,000 patients taking a copycat version of Novo Nordisk A/S’s Ozempic and Wegovy showed the shot was a safe and effective way to shed pounds.

But drugs like Ozempic have the potential to do much more than tackle diabetes and obesity. They have been found to treat cardiovascular and kidney disease, and they are also being tested for ...

Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage list for over two years, with different doses being listed in shortage ...

Telehealth companies selling low-cost, compounded versions of popular weight-loss drugs, including Ozempic and Wegovy, are drawing increased interest from employers, Bloomberg reported Oct. 29.

Telehealth companies Hims & Hers Health Inc., Noom Inc. and Sesame Inc. have lured individual customers with low-cost versions of popular weight-loss shots like Ozempic and Wegovy. Now ...